Choi Yu Hyeon, Jeong Hyung Joo, An Hong Yul, Kim You Sun, Lee Eui Jun, Lee Bongjin, Kang Hyoung Jin, Shin Hee Young, Park June Dong
Department of Pediatrics, Seoul National University Hospital, Seoul National University College of Medicine, Seoul, Korea.
Department of Pediatrics, Cancer Research Institute, Seoul National University College of Medicine, Seoul, Korea.
Pediatr Transplant. 2017 Dec;21(8). doi: 10.1111/petr.13062. Epub 2017 Oct 12.
PC are a main cause of death following HSCT in children. We aimed to evaluate early predictors of mortality in paediatric recipients with PCs. A retrospective observational study of 35 patients with 49 episodes of PI on chest radiography (of 124 patients) who had undergone HSCT at a tertiary university hospital between January 2011 and December 2012 was performed. During follow-up (median 26.1 months), 15 episodes led to death (30.6%). An aetiologic diagnosis was made by non-invasive tests in 24 episodes (49.0%) and by adding bronchoalveolar lavage and/or lung biopsy in 7 episodes with diagnostic yield (77.8%, P = .001). Thus, a specific diagnosis was obtained in 63.3% of the episodes. Aetiology identification and treatment modification after diagnosis did not decrease mortality (P = .057, P = .481). However, the number of organ dysfunctions at the beginning of PI was higher in the mortality group, compared to the survivor group (1.7 ± 1.2 vs 0.32 ± 0.59; P = .001). Hepatic dysfunction (OR, 11.145; 95% CI, 1.23 to 101.29; P = .032) and neutropaenia (OR, 10.558; 95% CI, 1.07 to 104.65; P = .044) were independently associated with risk of mortality. Therefore, hepatic dysfunction and neutropaenia are independent early predictors of mortality in HSCT recipients with PCs.
肺炎是儿童异基因造血干细胞移植(HSCT)后主要的死亡原因。我们旨在评估患有肺炎的儿科HSCT受者死亡的早期预测因素。对2011年1月至2012年12月在一所三级大学医院接受HSCT的124例患者中35例出现49次胸部X线肺炎发作的患者进行了回顾性观察研究。在随访期间(中位时间26.1个月),15次发作导致死亡(30.6%)。24次发作(49.0%)通过非侵入性检查做出病因诊断,7次发作通过支气管肺泡灌洗和/或肺活检确诊(诊断率77.8%,P = 0.001)。因此,63.3%的发作获得了明确诊断。诊断后病因识别和治疗调整并未降低死亡率(P = 0.057,P = 0.481)。然而,与存活组相比,肺炎发作开始时死亡组的器官功能障碍数量更多(1.7±1.2对0.32±0.59;P = 0.001)。肝功能障碍(OR,11.145;95%CI,1.23至101.29;P = 0.032)和中性粒细胞减少(OR,10.558;95%CI,1.07至104.65;P = 0.044)与死亡风险独立相关。因此,肝功能障碍和中性粒细胞减少是患有肺炎的HSCT受者死亡的独立早期预测因素。